Abbott Hits Teva With Another Suit Over Generic Simcor

Law360, New York (September 10, 2010, 12:48 PM EDT) -- Abbott Laboratories has stepped up its patent infringement battle against generic-drug maker Teva Pharmaceutical Industries Ltd. over efforts to introduce a copycat version of cholesterol treatment Simcor.

Abbott filed suit Wednesday in the U.S. District Court for the District of Delaware, where it also has suits pending against several drugmakers that have proposed generic versions of Simcor and Niaspan, a component of Simcor.

The suit came a response to Teva's abbreviated new drug application with the U.S. Food and Drug Administration to make generic Simcor tablets...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.